Long-term outcome of pleurodesis with OK-432 in metastatic breast cancer: a new risk model for success from an analysis of 75 cases
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Hematology,General Medicine,Surgery
Link
http://link.springer.com/content/pdf/10.1007/s10147-011-0312-5.pdf
Reference32 articles.
1. Marel M, Zrustova M, Stasny B et al (1993) The incidence of pleural effusion in a well-defined region. Epidemiologic study in central Bohemia. Chest 104:1486–1489
2. Figlin R, Mendoza E, Piantadosi S et al (1994) Intrapleural chemotherapy without pleurodesis for malignant pleural effusions. LCSG Trial 861. Chest 106(6 Suppl):363S–366S
3. American Thoracic Society (2000) Management of malignant pleural effusions. Am J Respir Crit Care Med 162:1987–2001
4. Martinez-Moragon E, Aparicio J, Sanchis J et al (1998) Malignant pleural effusion: prognostic factors for survival and response to chemical pleurodesis in a series of 120 cases. Respiration 65:108–113
5. Lynch TJ Jr (1993) Management of malignant pleural effusions. Chest 103(4 Suppl):385S–389S
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pleurodesis;Seminars in Respiratory and Critical Care Medicine;2019-06
2. Outcomes of bevacizumab combined with chemotherapy in lung adenocarcinoma-induced malignant pleural effusion;Thoracic Cancer;2018-01-03
3. Old age and underlying interstitial abnormalities are risk factors for development of ARDS after pleurodesis using limited amount of large particle size talc;Respirology;2017-10-04
4. Effects of programmed death-ligand 1 expression on OK-432 immunotherapy following transurethral resection in non-muscle invasive bladder cancer;Oncology Letters;2017-04-24
5. A propensity score-matched comparison of the efficacies of OK-432 and talc slurry for pleurodesis for malignant pleural effusion induced by lung adenocarcinoma;Respiratory Investigation;2016-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3